Brandy Perkins

1.9k total citations
18 papers, 1.4k citations indexed

About

Brandy Perkins is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Brandy Perkins has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Brandy Perkins's work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cell Adhesion Molecules Research (3 papers). Brandy Perkins is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cell Adhesion Molecules Research (3 papers). Brandy Perkins collaborates with scholars based in United States, Japan and United Kingdom. Brandy Perkins's co-authors include Richard J. Jones, Francis W. Luscinskas, Sunil K. Shaw, Jonathan M. Gerber, Marianna Zahurak, Milada S. Vala, Christopher J. Thoburn, Ephraim J. Fuchs, Leo Luznik and Christopher G. Kanakry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Brandy Perkins

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandy Perkins United States 13 578 497 440 369 218 18 1.4k
Jason S. Damiano United States 13 1.0k 1.8× 653 1.3× 379 0.9× 753 2.0× 342 1.6× 15 1.8k
Frédéric Barabé Canada 20 732 1.3× 416 0.8× 348 0.8× 286 0.8× 88 0.4× 38 1.3k
Rodrigo Jácamo United States 27 1.2k 2.0× 516 1.0× 361 0.8× 466 1.3× 138 0.6× 66 2.2k
Sabine Cerny‐Reiterer Austria 29 808 1.4× 849 1.7× 692 1.6× 453 1.2× 121 0.6× 65 2.2k
Brandon Harder United States 14 372 0.6× 246 0.5× 634 1.4× 332 0.9× 166 0.8× 19 1.4k
Frank Bautz Germany 11 489 0.8× 437 0.9× 568 1.3× 625 1.7× 135 0.6× 12 1.4k
Alexandra Schebesta Austria 12 586 1.0× 200 0.4× 759 1.7× 236 0.6× 56 0.3× 13 1.4k
Stephen Fitter Australia 24 709 1.2× 644 1.3× 201 0.5× 339 0.9× 542 2.5× 39 1.8k
Allison M. Baird United States 7 748 1.3× 490 1.0× 938 2.1× 338 0.9× 260 1.2× 8 1.9k
Ayako Arai Japan 28 539 0.9× 441 0.9× 578 1.3× 955 2.6× 131 0.6× 107 2.1k

Countries citing papers authored by Brandy Perkins

Since Specialization
Citations

This map shows the geographic impact of Brandy Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandy Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandy Perkins more than expected).

Fields of papers citing papers by Brandy Perkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandy Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandy Perkins. The network helps show where Brandy Perkins may publish in the future.

Co-authorship network of co-authors of Brandy Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of Brandy Perkins. A scholar is included among the top collaborators of Brandy Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandy Perkins. Brandy Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Karantanos, Theodoros, Patric Teodorescu, Brandy Perkins, et al.. (2022). The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia. Science Advances. 8(7). eabl8952–eabl8952. 10 indexed citations
2.
Karantanos, Theodoros, Patric Teodorescu, Marios Arvanitis, et al.. (2022). CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine. Haematologica. 108(7). 1886–1899. 8 indexed citations
3.
Perkins, Brandy, Margaret M. Showel, Philip Imus, et al.. (2022). CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia. Leukemia & lymphoma. 63(7). 1617–1623. 3 indexed citations
4.
Perkins, Brandy, Theodoros Karantanos, Mark J. Levis, et al.. (2020). Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes. Leukemia Research. 99. 106477–106477. 11 indexed citations
5.
Sharrow, Allison C., Brandy Perkins, Michael I. Collector, et al.. (2016). Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy. Gynecologic Oncology. 142(2). 341–348. 33 indexed citations
6.
Kanakry, Christopher G., Sudipto Ganguly, Marianna Zahurak, et al.. (2013). Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide. Science Translational Medicine. 5(211). 211ra157–211ra157. 240 indexed citations
7.
Ghiaur, Gabriel, et al.. (2013). Regulation of human hematopoietic stem cell self-renewal by the microenvironment’s control of retinoic acid signaling. Proceedings of the National Academy of Sciences. 110(40). 16121–16126. 106 indexed citations
8.
Gerber, Jonathan M., B. Douglas Smith, Hao Zhang, et al.. (2012). A clinically relevant population of leukemic CD34+CD38− cells in acute myeloid leukemia. Blood. 119(15). 3571–3577. 175 indexed citations
9.
Kasamon, Yvette L., Heather A. Jacene, Christopher D. Gocke, et al.. (2012). Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. Blood. 119(18). 4129–4132. 51 indexed citations
10.
Chun, Yong Soon, Takahiro Yoshida, Tsuyoshi Mori, et al.. (2012). Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors. Breast Cancer Research and Treatment. 135(1). 201–208. 20 indexed citations
11.
Gerber, Jonathan M., B. Douglas Smith, Hao Zhang, et al.. (2011). The Clinical Relevance of Acute Myeloid Leukemia Stem Cells. Blood. 118(21). 240–240. 3 indexed citations
12.
Gerber, Jonathan M., Qin Lu, Jeanne Kowalski, et al.. (2010). Characterization of chronic myeloid leukemia stem cells. American Journal of Hematology. 86(1). 31–37. 69 indexed citations
13.
Huang, Yi, Tracy Murray Stewart, Yu Wu, et al.. (2009). Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes. Clinical Cancer Research. 15(23). 7217–7228. 158 indexed citations
14.
Jones, Richard J., Christopher D. Gocke, Yvette L. Kasamon, et al.. (2009). Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood. 113(23). 5920–5926. 121 indexed citations
15.
16.
Shaw, Sunil K., et al.. (2001). Real-Time Imaging of Vascular Endothelial-Cadherin During Leukocyte Transmigration Across Endothelium. The Journal of Immunology. 167(4). 2323–2330. 238 indexed citations
17.
18.
Kalayoglu, Murat V., Brandy Perkins, & Gerald I. Byrne. (2001). -infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes and Infection. 3(12). 963–969. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason S. Damiano Breakdown of academic impact, for papers by Frédéric Barabé Breakdown of academic impact, for papers by Rodrigo Jácamo Breakdown of academic impact, for papers by Sabine Cerny‐Reiterer Breakdown of academic impact, for papers by Brandon Harder Breakdown of academic impact, for papers by Frank Bautz Breakdown of academic impact, for papers by Alexandra Schebesta Breakdown of academic impact, for papers by Stephen Fitter Breakdown of academic impact, for papers by Allison M. Baird Breakdown of academic impact, for papers by Ayako Arai
Rankless by CCL
2026